López ME, Ávila EL, Guerrero HI

Language: Spanish
References: 19
Page: 302-307
PDF size: 118.86 Kb.

ABSTRACT

Introduction: Portal hypertension is associated with splanchnic vasodilatation and baroreceptors activation with secondary renal vasoconstriction. Objective: To measure the pulsatility and resistance index in the renal arteries: Segmentaries and arcuates of both kidneys in cirrhotic patients Child-Pugh A, B, C classes and compared them with healthy controls. Patients and methods: Thirty patients with cirrhosis were included: Ten patients Child A, 10 were Child B and 10 Child C class and 10 healthy patients, we measured the resistance index (RI = [systolic peak velocity-minimum diastolic velocity]/systolic peak velocity) and the pulsatility index (PI = [systolic peak velocity-minimum diastolic velocity]/medium velocity) with Doppler spectral analysis. Results: The RI in controls had an average of 0.55 ± 0.11. In child A: 0.79 ± 0.114, in child B 0.77 ± 0.104 and in Child C 0.85 ± 0.037. For the pulsatility index the values were: 0.98 ± 0.21, 1.4 ± 0.105, 1.72 ± 0.206, and 2.04 ± 0.346, respectively. The resistances and pulsatility index were higher in patients with cirrhosis at the time to be compared with healthy controls, which represent a diminishment in blood flow. At the time to compare each one of the Child stages with controls, both index resulted higher in cirrhotic patients, but when we compared the cirrhotic patients between them, only difference for RI in child B vs. C was evident. The differences in PI were evident between each one of the Child classes. Discussion: The present study proved that a non invasive method like Doppler ultrasound is useful in the evaluation of the renal hemodynamic changes in cirrhotic patients with a good correlation between Child class and IP.

REFERENCES

1. Schrier RW, Arroyo V, Bernerdini M, et al. Peripheral arteriolar vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-7.

2. Martin PY, Ginés P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998; 339: 533-41.

3. Ginés P, Arroyo V. Hepatorenal syndrome. J Am Soc Nephrol 1999; 10: 1833-9.

4. Petersen LJ, Petersen JR, Talleruphuus U, et al. The pulsatility index and de resistive index in renal arteries. Associations with long-term progression in chronic renal failure. Nephrol Dial transplant 1997; 12: 1376-80.

5. Koda M, Murawaki Y, Kawasaki H. Renovascular resistance assessed by Doppler ultrasonography in patients with chronic liver disease. J Gastroenterol Hepatol 2000; 15: 1424-9.

6. Heine GH, Girndt M, Sester U, Kohler H. No rise in renal Doppler resistance indices at peak serum levels of cyclosporine A in stable kidney transplant patients. Nephrol Dial Transplant 2003; 18: 1639-43.

7. Kastelan S, Ljubicic N, Kastelan Z, Ostojic R, Uravic M. The role of duplex-Doppler ultrasonography in the diagnosis of renal dysfunction and hepatorenal syndrome in patients with liver cirrhosis. Hepatogastroenterology 2004; 59: 1408-12.

8. Bosch J, García Pagán JC. Complications of cirrhosis. I. Portal hypertension. J Hepatology 2000; 32: 141-56.

9. Wiest R, Groszmann RJ. The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough. Hepatology 2002; 35: 478-91.

10. Ros J, Claria J, Jiménez W, et al. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis. Hepatology 1995; 22: 915-20.

11. Maroto A, Ginés A, Salo J, et al. Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index. Hepatology 1994; 20: 839-44.

12. Koda M, Murawaki Y, Kawasaki H. Renovascular resistance assessed by color Doppler ultrasonography in patients with chronic liver disease. J Gastroenterol Hepatol 2000; 15: 1424-9.

13. Sacerdoti D, Gaiani S, Buonamico P, et al. Interobserver and interequipment variability of hepatic, splenic and renal arterial Doppler resistance indices in normal subjects and patients with cirrhosis. J Hepatol 1997; 27: 986-92.

14. Rivolta R, Maggi A, Cazzaniga M, et al. Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites. Hepatology 1998; 28(5): 1235-4.

15. Sacerdoti D, Bolognesi M, Merkel C, Angeli P, Gatta A. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatology 1993; 17: 219-24.

16. Roberto de Franchis. Updating Consensus in Portal Hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846-52.

17. Kalambokis G, Economou M, Fotopoulos A, Pappas C, et al. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites. Am J Gastroenterol 2005;100: 879-85.

18. Derchi LE, Leoncini G, Parodi D, Vazzi F, et al. Mild renal dysfunction and renal vascular resistance in primary hypertension. Am J Hypertens 2005; 18: 966-71.

19. Okura T, Watanabe S, Miyoshi K, Fukuoka T, et al. Intrarenal and carotid hemodynamics in patients with essential hypertension. Am J Hypertens 2004; 17: 240-4.